Business Description
Nexalis Therapeutics Ltd
ISIN : AU0000456733
Description
Nexalis Therapeutics Ltd is an Australian clinical-stage drug development company that is focused on developing therapies to address unmet medical needs in pain management and mental health sectors. Its pipeline includes three clinical drug candidates focused on treatment-resistant depression (SRX-25), breakthrough cancer pain (IRX-211), and panic disorder (IRX-616a), each addressing areas of unmet medical need and potential commercial demand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.59 | |||||
Equity-to-Asset | -0.97 | |||||
Debt-to-Equity | -0.63 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14 | |||||
3-Year EPS without NRI Growth Rate | 10.1 | |||||
3-Year FCF Growth Rate | 28.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.19 | |||||
9-Day RSI | 57.96 | |||||
14-Day RSI | 50.98 | |||||
3-1 Month Momentum % | 4.17 | |||||
6-1 Month Momentum % | 8.7 | |||||
12-1 Month Momentum % | -37.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.58 | |||||
Quick Ratio | 0.58 | |||||
Cash Ratio | 0.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.3 | |||||
Shareholder Yield % | -25.51 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -144.64 | |||||
ROIC % | -1364.34 | |||||
3-Year ROIIC % | -196.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -3.29 | |||||
EV-to-EBITDA | -3.29 | |||||
EV-to-FCF | -4.05 | |||||
Earnings Yield (Greenblatt) % | -30.44 | |||||
FCF Yield % | -19.5 |
GF Valueâ„¢
Nexalis Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nexalis Therapeutics Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nexalis Therapeutics Ltd
No articles.